- Home
- PDLB vs ATAI Comparison
PDLB vs ATAI Comparison
Compare PDLB & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDLB
- ATAI
- Stock Information
- Founded
- PDLB 1960
- ATAI 2018
- Country
- PDLB United States
- ATAI Germany
- Employees
- PDLB N/A
- ATAI N/A
- Industry
- PDLB
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- PDLB
- ATAI Health Care
- Exchange
- PDLB Nasdaq
- ATAI Nasdaq
- Market Cap
- PDLB 256.3M
- ATAI 214.8M
- IPO Year
- PDLB 2017
- ATAI 2021
- Fundamental
- Price
- PDLB $12.77
- ATAI $1.61
- Analyst Decision
- PDLB
- ATAI Strong Buy
- Analyst Count
- PDLB 0
- ATAI 3
- Target Price
- PDLB N/A
- ATAI $10.50
- AVG Volume (30 Days)
- PDLB 43.6K
- ATAI 1.7M
- Earning Date
- PDLB 10-30-2024
- ATAI 11-13-2024
- Dividend Yield
- PDLB N/A
- ATAI N/A
- EPS Growth
- PDLB N/A
- ATAI N/A
- EPS
- PDLB 0.37
- ATAI N/A
- Revenue
- PDLB $79,488,000.00
- ATAI $331,000.00
- Revenue This Year
- PDLB N/A
- ATAI $44.72
- Revenue Next Year
- PDLB $11.39
- ATAI N/A
- P/E Ratio
- PDLB $34.81
- ATAI N/A
- Revenue Growth
- PDLB 33.32
- ATAI N/A
- 52 Week Low
- PDLB $7.89
- ATAI $1.03
- 52 Week High
- PDLB $13.15
- ATAI $2.85
- Technical
- Relative Strength Index (RSI)
- PDLB 63.82
- ATAI 66.74
- Support Level
- PDLB $12.68
- ATAI $1.25
- Resistance Level
- PDLB $13.15
- ATAI $1.65
- Average True Range (ATR)
- PDLB 0.32
- ATAI 0.15
- MACD
- PDLB 0.09
- ATAI 0.04
- Stochastic Oscillator
- PDLB 80.00
- ATAI 93.29
About PDLB Ponce Financial Group Inc.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.